Rank | Gene Set | Z-score |
---|---|---|
1 | viral transcription (GO:0019083) | 9.94407879 |
2 | translational termination (GO:0006415) | 9.46313261 |
3 | ribosomal small subunit biogenesis (GO:0042274) | 8.82275386 |
4 | ribosomal small subunit assembly (GO:0000028) | 8.57013201 |
5 | translational elongation (GO:0006414) | 8.03821140 |
6 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 7.98215107 |
7 | protein targeting to ER (GO:0045047) | 7.84045904 |
8 | cotranslational protein targeting to membrane (GO:0006613) | 7.81798988 |
9 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 7.52650852 |
10 | viral life cycle (GO:0019058) | 7.52431403 |
11 | cellular protein complex disassembly (GO:0043624) | 7.44238252 |
12 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 7.36332094 |
13 | protein localization to endoplasmic reticulum (GO:0070972) | 7.28485833 |
14 | translational initiation (GO:0006413) | 6.90313912 |
15 | maturation of SSU-rRNA (GO:0030490) | 6.85203930 |
16 | protein complex disassembly (GO:0043241) | 6.77355085 |
17 | macromolecular complex disassembly (GO:0032984) | 6.33897312 |
18 | ribosomal large subunit biogenesis (GO:0042273) | 5.42323454 |
19 | protein targeting to membrane (GO:0006612) | 5.32004161 |
20 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 4.95760259 |
21 | protein maturation by protein folding (GO:0022417) | 4.79119624 |
22 | mRNA catabolic process (GO:0006402) | 4.69873438 |
23 | ncRNA 3-end processing (GO:0043628) | 4.69599610 |
24 | translation (GO:0006412) | 4.60788325 |
25 | RNA catabolic process (GO:0006401) | 4.47659763 |
26 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.25830772 |
27 | ribonucleoprotein complex biogenesis (GO:0022613) | 4.13265939 |
28 | nuclear envelope reassembly (GO:0031468) | 3.83397078 |
29 | mitotic nuclear envelope reassembly (GO:0007084) | 3.83397078 |
30 | proteasome assembly (GO:0043248) | 3.83391211 |
31 | pyrimidine-containing compound salvage (GO:0008655) | 3.83231019 |
32 | pyrimidine nucleoside salvage (GO:0043097) | 3.83231019 |
33 | establishment of viral latency (GO:0019043) | 3.81990781 |
34 | establishment of protein localization to membrane (GO:0090150) | 3.70151225 |
35 | regulation of mitochondrial translation (GO:0070129) | 3.62575330 |
36 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 3.59068633 |
37 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.55928446 |
38 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.52070887 |
39 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.50090657 |
40 | establishment of integrated proviral latency (GO:0075713) | 3.46529653 |
41 | DNA damage response, detection of DNA damage (GO:0042769) | 3.44080948 |
42 | regulation of superoxide anion generation (GO:0032928) | 3.43968672 |
43 | nucleoside salvage (GO:0043174) | 3.43334245 |
44 | negative regulation of RNA splicing (GO:0033119) | 3.33972518 |
45 | formation of translation preinitiation complex (GO:0001731) | 3.32917766 |
46 | DNA unwinding involved in DNA replication (GO:0006268) | 3.31242601 |
47 | negative regulation of ligase activity (GO:0051352) | 3.27950582 |
48 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.27950582 |
49 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.27613422 |
50 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.27126502 |
51 | protein targeting (GO:0006605) | 3.26885165 |
52 | DNA deamination (GO:0045006) | 3.24480531 |
53 | rRNA processing (GO:0006364) | 3.20997910 |
54 | chaperone-mediated protein transport (GO:0072321) | 3.20496473 |
55 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.19035823 |
56 | trophectodermal cell differentiation (GO:0001829) | 3.18586482 |
57 | heme biosynthetic process (GO:0006783) | 3.16631806 |
58 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.14347653 |
59 | maternal placenta development (GO:0001893) | 3.13361107 |
60 | rRNA metabolic process (GO:0016072) | 3.12346744 |
61 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.12199090 |
62 | establishment of protein localization to organelle (GO:0072594) | 3.11730555 |
63 | base-excision repair, AP site formation (GO:0006285) | 3.07482108 |
64 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 3.07129316 |
65 | protein targeting to mitochondrion (GO:0006626) | 3.03584247 |
66 | deoxyribonucleotide catabolic process (GO:0009264) | 3.03212324 |
67 | GDP-mannose metabolic process (GO:0019673) | 3.02944970 |
68 | COPI coating of Golgi vesicle (GO:0048205) | 3.01206066 |
69 | Golgi transport vesicle coating (GO:0048200) | 3.01206066 |
70 | deoxyribose phosphate catabolic process (GO:0046386) | 3.00435262 |
71 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.99801607 |
72 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.98857336 |
73 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.97791340 |
74 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.96908603 |
75 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.96108470 |
76 | cellular component biogenesis (GO:0044085) | 2.95543613 |
77 | UTP biosynthetic process (GO:0006228) | 2.95105371 |
78 | metallo-sulfur cluster assembly (GO:0031163) | 2.94141154 |
79 | iron-sulfur cluster assembly (GO:0016226) | 2.94141154 |
80 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.92826919 |
81 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.92826919 |
82 | alternative mRNA splicing, via spliceosome (GO:0000380) | 2.92568941 |
83 | response to peptidoglycan (GO:0032494) | 2.92376184 |
84 | nucleosome disassembly (GO:0006337) | 2.91786166 |
85 | protein-DNA complex disassembly (GO:0032986) | 2.91786166 |
86 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 2.91115787 |
87 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.90186161 |
88 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.88073573 |
89 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.88073573 |
90 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.88073573 |
91 | cellular component disassembly (GO:0022411) | 2.88036121 |
92 | ribosome biogenesis (GO:0042254) | 2.87612144 |
93 | GTP biosynthetic process (GO:0006183) | 2.87309797 |
94 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.86755546 |
95 | regulation of protein heterodimerization activity (GO:0043497) | 2.86248060 |
96 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.86242597 |
97 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 2.85179070 |
98 | rRNA modification (GO:0000154) | 2.84367082 |
99 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.84093765 |
100 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.84093765 |
101 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.79420056 |
102 | positive regulation of ligase activity (GO:0051351) | 2.79002040 |
103 | protein localization to membrane (GO:0072657) | 2.78629159 |
104 | megakaryocyte development (GO:0035855) | 2.78278620 |
105 | pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209) | 2.77735369 |
106 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.76809630 |
107 | viral protein processing (GO:0019082) | 2.76081041 |
108 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.76074076 |
109 | de novo protein folding (GO:0006458) | 2.76048785 |
110 | establishment of protein localization to mitochondrion (GO:0072655) | 2.74855625 |
111 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.74437606 |
112 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.72012990 |
113 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.71313781 |
114 | modulation by symbiont of host immune response (GO:0052553) | 2.71313781 |
115 | positive regulation by symbiont of host defense response (GO:0052509) | 2.71313781 |
116 | modulation by symbiont of host defense response (GO:0052031) | 2.71313781 |
117 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.71313781 |
118 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.71313781 |
119 | T cell apoptotic process (GO:0070231) | 2.71043873 |
120 | CTP biosynthetic process (GO:0006241) | 2.70926388 |
121 | CTP metabolic process (GO:0046036) | 2.70926388 |
122 | neutrophil activation involved in immune response (GO:0002283) | 2.70078605 |
123 | porphyrin-containing compound biosynthetic process (GO:0006779) | 2.68984592 |
124 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.68777237 |
125 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.68777237 |
126 | DNA strand elongation (GO:0022616) | 2.68253184 |
127 | protein localization to mitochondrion (GO:0070585) | 2.68246770 |
128 | de novo posttranslational protein folding (GO:0051084) | 2.68013931 |
129 | virion assembly (GO:0019068) | 2.66690306 |
130 | heterochromatin organization (GO:0070828) | 2.66183378 |
131 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.65957246 |
132 | spliceosomal snRNP assembly (GO:0000387) | 2.64577084 |
133 | spliceosomal complex assembly (GO:0000245) | 2.64343511 |
134 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.62927368 |
135 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.62233093 |
136 | lipopolysaccharide metabolic process (GO:0008653) | 2.61428721 |
137 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.61389184 |
138 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.59502337 |
139 | ATP synthesis coupled proton transport (GO:0015986) | 2.59056643 |
140 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.59056643 |
141 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 2.57594097 |
142 | UTP metabolic process (GO:0046051) | 2.56186527 |
143 | pentose metabolic process (GO:0019321) | 2.55548259 |
144 | negative regulation of mRNA processing (GO:0050686) | 2.54351816 |
145 | regulation of ligase activity (GO:0051340) | 2.53223108 |
146 | deoxyribose phosphate metabolic process (GO:0019692) | 2.52778087 |
147 | pinocytosis (GO:0006907) | 2.52719373 |
148 | negative regulation of B cell apoptotic process (GO:0002903) | 2.52005150 |
149 | negative regulation of mRNA metabolic process (GO:1903312) | 2.51648110 |
150 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.50965382 |
151 | pyrimidine ribonucleoside triphosphate metabolic process (GO:0009208) | 2.49631861 |
152 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.49007917 |
153 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.47868242 |
154 | pentose-phosphate shunt (GO:0006098) | 2.44097891 |
155 | mitochondrial calcium ion transport (GO:0006851) | 2.43643715 |
156 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.43307799 |
157 | negative regulation of protein ubiquitination (GO:0031397) | 2.42724918 |
158 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.42461703 |
159 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.42422829 |
160 | pyrimidine nucleoside biosynthetic process (GO:0046134) | 2.41079064 |
161 | DNA replication checkpoint (GO:0000076) | 2.40784172 |
162 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.40500000 |
163 | termination of RNA polymerase II transcription (GO:0006369) | 2.39136891 |
164 | chromatin assembly (GO:0031497) | 2.36759383 |
165 | lymphocyte apoptotic process (GO:0070227) | 2.34058524 |
166 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377) | 2.31768514 |
167 | mRNA splicing, via spliceosome (GO:0000398) | 2.31768514 |
168 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.28588744 |
169 | positive regulation of transcription regulatory region DNA binding (GO:2000679) | 2.27745999 |
170 | protein localization to organelle (GO:0033365) | 2.27376739 |
171 | RNA splicing, via transesterification reactions (GO:0000375) | 2.27066486 |
172 | regulation of chromatin binding (GO:0035561) | 2.26647016 |
173 | tetrapyrrole biosynthetic process (GO:0033014) | 2.25863347 |
174 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 2.25822955 |
175 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 2.25348757 |
176 | ribonucleoprotein complex assembly (GO:0022618) | 2.22311782 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.28310048 |
2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.24736256 |
3 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.87044987 |
4 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.44204934 |
5 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.77798327 |
6 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.64135381 |
7 | * XRN2_22483619_ChIP-Seq_HELA_Human | 2.35960028 |
8 | MYC_22102868_ChIP-Seq_BL_Human | 2.30895109 |
9 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.30673656 |
10 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.29568531 |
11 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.28382717 |
12 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.25716699 |
13 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.17671295 |
14 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.15188515 |
15 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.15001605 |
16 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.07159541 |
17 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.04520340 |
18 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.03844213 |
19 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.98508803 |
20 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.89666805 |
21 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.88011649 |
22 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.87091826 |
23 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.83335435 |
24 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.78742068 |
25 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.75252797 |
26 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.74910294 |
27 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.72427624 |
28 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.71739574 |
29 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.71082393 |
30 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.70981585 |
31 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.70343493 |
32 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.69331297 |
33 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.65901453 |
34 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.65379374 |
35 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.64602132 |
36 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.63048707 |
37 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.62570385 |
38 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.62539066 |
39 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.57875867 |
40 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.57655372 |
41 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.56480011 |
42 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.54407146 |
43 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.53251001 |
44 | MAF_26560356_Chip-Seq_TH1_Human | 1.52759035 |
45 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.51606668 |
46 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.51508631 |
47 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.50144446 |
48 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.47618475 |
49 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.47213325 |
50 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47141093 |
51 | UTX_26944678_Chip-Seq_JUKART_Human | 1.45294770 |
52 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.45256282 |
53 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.44870951 |
54 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.44018425 |
55 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.42579310 |
56 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.41331732 |
57 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.40521416 |
58 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.39259270 |
59 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38420884 |
60 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.38100990 |
61 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.37190580 |
62 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.36719959 |
63 | MAF_26560356_Chip-Seq_TH2_Human | 1.36718882 |
64 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.35805831 |
65 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.35536495 |
66 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35232473 |
67 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.34656717 |
68 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.34193560 |
69 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.33733815 |
70 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.32412356 |
71 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.32188951 |
72 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.31797803 |
73 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.31744219 |
74 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.31297000 |
75 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.30785397 |
76 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.30478296 |
77 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.29433653 |
78 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.28912094 |
79 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.28607447 |
80 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.28382183 |
81 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.27221730 |
82 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.26350271 |
83 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.25642698 |
84 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.25608014 |
85 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.25281838 |
86 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.23330919 |
87 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.22714829 |
88 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.21302993 |
89 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.21120815 |
90 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.20324554 |
91 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.19912582 |
92 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.19277280 |
93 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.18805364 |
94 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.15909220 |
95 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.15768558 |
96 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.15347250 |
97 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.15187397 |
98 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.13468068 |
99 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.13104420 |
100 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.12598403 |
101 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.12453106 |
102 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.11153263 |
103 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.09963812 |
104 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.08824870 |
105 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.08125362 |
106 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.07840117 |
107 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.07830504 |
108 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.07256907 |
109 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.06589245 |
110 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.05541354 |
111 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.04386164 |
112 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.04180873 |
113 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.02917060 |
114 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.02602871 |
115 | ATF3_27146783_Chip-Seq_COLON_Human | 1.01675335 |
116 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.01644484 |
117 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01588651 |
118 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.00894385 |
119 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.00613096 |
120 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.00611290 |
121 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.00384494 |
122 | MYB_26560356_Chip-Seq_TH2_Human | 1.00293695 |
123 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.00178026 |
124 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.99590762 |
125 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.99502469 |
126 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.99502261 |
127 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.99144870 |
128 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.99034980 |
129 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.98559082 |
130 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.98004407 |
131 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.97854148 |
132 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.96321484 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002163_abnormal_gland_morphology | 4.23140649 |
2 | MP0003693_abnormal_embryo_hatching | 3.79528998 |
3 | MP0003183_abnormal_peptide_metabolism | 3.65623033 |
4 | MP0005451_abnormal_body_composition | 3.44404393 |
5 | MP0008260_abnormal_autophagy | 3.35483597 |
6 | MP0003806_abnormal_nucleotide_metabolis | 3.26920922 |
7 | MP0009379_abnormal_foot_pigmentation | 3.20310314 |
8 | MP0004957_abnormal_blastocyst_morpholog | 2.94146585 |
9 | MP0005058_abnormal_lysosome_morphology | 2.91845765 |
10 | MP0010352_gastrointestinal_tract_polyps | 2.74960281 |
11 | MP0002396_abnormal_hematopoietic_system | 2.62358821 |
12 | MP0003656_abnormal_erythrocyte_physiolo | 2.48550724 |
13 | MP0008058_abnormal_DNA_repair | 2.46713942 |
14 | MP0002132_abnormal_respiratory_system | 2.35618598 |
15 | MP0003191_abnormal_cellular_cholesterol | 2.24767741 |
16 | MP0005379_endocrine/exocrine_gland_phen | 2.20870148 |
17 | MP0000685_abnormal_immune_system | 2.19775026 |
18 | MP0003111_abnormal_nucleus_morphology | 2.19529521 |
19 | MP0003186_abnormal_redox_activity | 1.96746250 |
20 | MP0009333_abnormal_splenocyte_physiolog | 1.93036644 |
21 | MP0008932_abnormal_embryonic_tissue | 1.91867100 |
22 | MP0003567_abnormal_fetal_cardiomyocyte | 1.90266594 |
23 | MP0009278_abnormal_bone_marrow | 1.87315601 |
24 | MP0000490_abnormal_crypts_of | 1.80940703 |
25 | MP0006036_abnormal_mitochondrial_physio | 1.74256805 |
26 | MP0006035_abnormal_mitochondrial_morpho | 1.71598684 |
27 | MP0003436_decreased_susceptibility_to | 1.70225880 |
28 | MP0003303_peritoneal_inflammation | 1.65532406 |
29 | MP0002398_abnormal_bone_marrow | 1.64164704 |
30 | MP0003786_premature_aging | 1.63759642 |
31 | MP0001800_abnormal_humoral_immune | 1.62756697 |
32 | MP0002419_abnormal_innate_immunity | 1.61728311 |
33 | MP0003077_abnormal_cell_cycle | 1.60547853 |
34 | MP0001545_abnormal_hematopoietic_system | 1.58580882 |
35 | MP0005397_hematopoietic_system_phenotyp | 1.58580882 |
36 | MP0004808_abnormal_hematopoietic_stem | 1.57912869 |
37 | MP0002166_altered_tumor_susceptibility | 1.56134886 |
38 | MP0000703_abnormal_thymus_morphology | 1.55122721 |
39 | MP0003123_paternal_imprinting | 1.54674055 |
40 | MP0003866_abnormal_defecation | 1.49059546 |
41 | MP0001873_stomach_inflammation | 1.44234739 |
42 | MP0003763_abnormal_thymus_physiology | 1.43065763 |
43 | MP0001727_abnormal_embryo_implantation | 1.42074551 |
44 | MP0002277_abnormal_respiratory_mucosa | 1.40532317 |
45 | MP0003221_abnormal_cardiomyocyte_apopto | 1.37880245 |
46 | MP0001835_abnormal_antigen_presentation | 1.36697436 |
47 | MP0003724_increased_susceptibility_to | 1.35531342 |
48 | MP0000689_abnormal_spleen_morphology | 1.35272250 |
49 | MP0000750_abnormal_muscle_regeneration | 1.34711412 |
50 | MP0002452_abnormal_antigen_presenting | 1.33569571 |
51 | MP0003300_gastrointestinal_ulcer | 1.33478136 |
52 | MP0005083_abnormal_biliary_tract | 1.32331560 |
53 | MP0005174_abnormal_tail_pigmentation | 1.32206803 |
54 | MP0010030_abnormal_orbit_morphology | 1.30171341 |
55 | MP0002722_abnormal_immune_system | 1.30095824 |
56 | MP0008007_abnormal_cellular_replicative | 1.30022901 |
57 | MP0001790_abnormal_immune_system | 1.29299733 |
58 | MP0005387_immune_system_phenotype | 1.29299733 |
59 | MP0000678_abnormal_parathyroid_gland | 1.29155281 |
60 | MP0000358_abnormal_cell_content/ | 1.28455617 |
61 | MP0002429_abnormal_blood_cell | 1.27576144 |
62 | MP0002420_abnormal_adaptive_immunity | 1.26019324 |
63 | MP0005076_abnormal_cell_differentiation | 1.25242395 |
64 | MP0010155_abnormal_intestine_physiology | 1.24177782 |
65 | MP0001819_abnormal_immune_cell | 1.23201391 |
66 | MP0008057_abnormal_DNA_replication | 1.22513906 |
67 | MP0004858_abnormal_nervous_system | 1.21765303 |
68 | MP0005000_abnormal_immune_tolerance | 1.20962204 |
69 | MP0001730_embryonic_growth_arrest | 1.20517176 |
70 | MP0000350_abnormal_cell_proliferation | 1.20438353 |
71 | MP0003828_pulmonary_edema | 1.20368112 |
72 | MP0000716_abnormal_immune_system | 1.17376265 |
73 | MP0000749_muscle_degeneration | 1.16219608 |
74 | MP0002405_respiratory_system_inflammati | 1.16165625 |
75 | MP0005501_abnormal_skin_physiology | 1.14145568 |
76 | MP0002723_abnormal_immune_serum | 1.13259680 |
77 | MP0000313_abnormal_cell_death | 1.11855493 |
78 | MP0001533_abnormal_skeleton_physiology | 1.10685187 |
79 | MP0002653_abnormal_ependyma_morphology | 1.10461758 |
80 | MP0006082_CNS_inflammation | 1.09961256 |
81 | MP0003075_altered_response_to | 1.09424312 |
82 | MP0005464_abnormal_platelet_physiology | 1.07624654 |
83 | MP0008469_abnormal_protein_level | 1.06672216 |
84 | MP0001697_abnormal_embryo_size | 1.06518661 |
85 | MP0005025_abnormal_response_to | 1.06241430 |
86 | MP0002080_prenatal_lethality | 1.04561890 |
87 | MP0002019_abnormal_tumor_incidence | 1.03952705 |
88 | MP0002148_abnormal_hypersensitivity_rea | 1.03711511 |
89 | MP0002210_abnormal_sex_determination | 1.02702961 |
90 | MP0003941_abnormal_skin_development | 1.02655767 |
91 | MP0009764_decreased_sensitivity_to | 1.02052862 |
92 | MP0009840_abnormal_foam_cell | 1.01433850 |
93 | MP0008789_abnormal_olfactory_epithelium | 1.01363502 |
94 | MP0003566_abnormal_cell_adhesion | 1.01128952 |
95 | MP0005670_abnormal_white_adipose | 1.00904900 |
96 | MP0004510_myositis | 1.00842495 |
97 | MP0010094_abnormal_chromosome_stability | 0.99772498 |
98 | MP0009785_altered_susceptibility_to | 0.95972804 |
99 | MP0003172_abnormal_lysosome_physiology | 0.95904896 |
100 | MP0002909_abnormal_adrenal_gland | 0.95470590 |
101 | MP0003315_abnormal_perineum_morphology | 0.95172243 |
102 | MP0004233_abnormal_muscle_weight | 0.94292714 |
103 | MP0000733_abnormal_muscle_development | 0.94075306 |
104 | MP0000477_abnormal_intestine_morphology | 0.93991800 |
105 | MP0003119_abnormal_digestive_system | 0.93000530 |
106 | MP0001845_abnormal_inflammatory_respons | 0.92733952 |
107 | MP0005623_abnormal_meninges_morphology | 0.91943596 |
108 | MP0005384_cellular_phenotype | 0.90676142 |
109 | MP0000858_altered_metastatic_potential | 0.90546205 |
110 | MP0005319_abnormal_enzyme/_coenzyme | 0.88953779 |
111 | MP0005671_abnormal_response_to | 0.88863839 |
112 | MP0000613_abnormal_salivary_gland | 0.88012393 |
113 | MP0001929_abnormal_gametogenesis | 0.86323028 |
114 | MP0002084_abnormal_developmental_patter | 0.86247465 |
115 | MP0002877_abnormal_melanocyte_morpholog | 0.85878345 |
116 | MP0002086_abnormal_extraembryonic_tissu | 0.85689961 |
117 | MP0005084_abnormal_gallbladder_morpholo | 0.85448943 |
118 | MP0003718_maternal_effect | 0.84573571 |
119 | MP0000465_gastrointestinal_hemorrhage | 0.82366955 |
120 | MP0006292_abnormal_olfactory_placode | 0.80618042 |
121 | MP0002234_abnormal_pharynx_morphology | 0.79993024 |
122 | MP0009765_abnormal_xenobiotic_induced | 0.79483563 |
123 | MP0002088_abnormal_embryonic_growth/wei | 0.79331152 |
124 | MP0008877_abnormal_DNA_methylation | 0.78989159 |
125 | MP0002085_abnormal_embryonic_tissue | 0.78277697 |
126 | MP0005330_cardiomyopathy | 0.77958070 |
127 | MP0004197_abnormal_fetal_growth/weight/ | 0.76870822 |
128 | MP0000343_altered_response_to | 0.76616797 |
129 | MP0001672_abnormal_embryogenesis/_devel | 0.76485423 |
130 | MP0005380_embryogenesis_phenotype | 0.76485423 |
131 | MP0003984_embryonic_growth_retardation | 0.76170586 |
132 | MP0005257_abnormal_intraocular_pressure | 0.75834248 |
133 | MP0010630_abnormal_cardiac_muscle | 0.75360425 |
134 | MP0005410_abnormal_fertilization | 0.74947590 |
135 | MP0005165_increased_susceptibility_to | 0.74849913 |
136 | MP0000751_myopathy | 0.73941222 |
137 | MP0001853_heart_inflammation | 0.73578035 |
138 | MP0001145_abnormal_male_reproductive | 0.73004591 |
139 | MP0002796_impaired_skin_barrier | 0.72498600 |
140 | MP0004947_skin_inflammation | 0.71400382 |
141 | MP0009931_abnormal_skin_appearance | 0.70950080 |
142 | MP0002006_tumorigenesis | 0.68695559 |
143 | MP0005023_abnormal_wound_healing | 0.67571663 |
144 | MP0002282_abnormal_trachea_morphology | 0.66790026 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Reticulocytopenia (HP:0001896) | 6.82682302 |
2 | Abnormality of cells of the erythroid lineage (HP:0012130) | 6.52180625 |
3 | Abnormal number of erythroid precursors (HP:0012131) | 5.88310993 |
4 | Macrocytic anemia (HP:0001972) | 4.94587829 |
5 | Carpal bone hypoplasia (HP:0001498) | 4.70358234 |
6 | Pallor (HP:0000980) | 4.50838586 |
7 | J-shaped sella turcica (HP:0002680) | 4.49509057 |
8 | Abnormal hemoglobin (HP:0011902) | 3.87925932 |
9 | Recurrent bronchitis (HP:0002837) | 3.83447342 |
10 | Flat acetabular roof (HP:0003180) | 3.69669920 |
11 | Ragged-red muscle fibers (HP:0003200) | 3.66485005 |
12 | Diastasis recti (HP:0001540) | 3.61531055 |
13 | Abnormality of macrophages (HP:0004311) | 3.61002766 |
14 | Thoracolumbar scoliosis (HP:0002944) | 3.42410615 |
15 | Microvesicular hepatic steatosis (HP:0001414) | 3.39402777 |
16 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 3.39206284 |
17 | Abnormality of glycolipid metabolism (HP:0010969) | 3.31170176 |
18 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.31170176 |
19 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.31170176 |
20 | Broad alveolar ridges (HP:0000187) | 3.28666819 |
21 | Thrombocytosis (HP:0001894) | 3.27134549 |
22 | Vertebral arch anomaly (HP:0008438) | 3.25539125 |
23 | Rough bone trabeculation (HP:0100670) | 3.13203819 |
24 | Abnormality of reticulocytes (HP:0004312) | 3.04990444 |
25 | Microretrognathia (HP:0000308) | 3.00281057 |
26 | Concave nail (HP:0001598) | 2.97998007 |
27 | Degeneration of anterior horn cells (HP:0002398) | 2.94415295 |
28 | Abnormality of the anterior horn cell (HP:0006802) | 2.94415295 |
29 | Acute encephalopathy (HP:0006846) | 2.89780827 |
30 | Recurrent abscess formation (HP:0002722) | 2.88275149 |
31 | Beaking of vertebral bodies (HP:0004568) | 2.82385032 |
32 | Increased serum pyruvate (HP:0003542) | 2.81466892 |
33 | Upper limb muscle weakness (HP:0003484) | 2.80743021 |
34 | Hepatic necrosis (HP:0002605) | 2.77792060 |
35 | Achilles tendon contracture (HP:0001771) | 2.77567947 |
36 | Increased CSF lactate (HP:0002490) | 2.77469100 |
37 | Deformed sella turcica (HP:0002681) | 2.76828856 |
38 | Type I transferrin isoform profile (HP:0003642) | 2.76482025 |
39 | Abnormality of glycolysis (HP:0004366) | 2.75330352 |
40 | Exercise intolerance (HP:0003546) | 2.73744568 |
41 | Dysostosis multiplex (HP:0000943) | 2.69732248 |
42 | Aplastic anemia (HP:0001915) | 2.66505135 |
43 | Flared iliac wings (HP:0002869) | 2.64253879 |
44 | Rectal prolapse (HP:0002035) | 2.62995304 |
45 | Abnormal gallbladder physiology (HP:0012438) | 2.62870742 |
46 | Cholecystitis (HP:0001082) | 2.62870742 |
47 | Amyloidosis (HP:0011034) | 2.60199504 |
48 | Mucopolysacchariduria (HP:0008155) | 2.58042857 |
49 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.58042857 |
50 | Recurrent bacterial skin infections (HP:0005406) | 2.53512926 |
51 | Multiple enchondromatosis (HP:0005701) | 2.50133389 |
52 | Lactic acidosis (HP:0003128) | 2.49575490 |
53 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.47238125 |
54 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.47238125 |
55 | Abnormal protein glycosylation (HP:0012346) | 2.47238125 |
56 | Abnormal glycosylation (HP:0012345) | 2.47238125 |
57 | Rhabdomyolysis (HP:0003201) | 2.42472111 |
58 | Increased intramyocellular lipid droplets (HP:0012240) | 2.41164755 |
59 | Increased serum lactate (HP:0002151) | 2.40545065 |
60 | Abnormal trabecular bone morphology (HP:0100671) | 2.39497772 |
61 | Abnormality of the sella turcica (HP:0002679) | 2.39373537 |
62 | Nasal polyposis (HP:0100582) | 2.39297175 |
63 | Progressive external ophthalmoplegia (HP:0000590) | 2.38985659 |
64 | Progressive macrocephaly (HP:0004481) | 2.38118649 |
65 | Abnormality of the Achilles tendon (HP:0005109) | 2.35629668 |
66 | Abnormality of the nasal mucosa (HP:0000433) | 2.35611486 |
67 | Abnormality of the lumbar spine (HP:0100712) | 2.33868967 |
68 | Prolonged neonatal jaundice (HP:0006579) | 2.32232129 |
69 | Thickened calvaria (HP:0002684) | 2.30373699 |
70 | Broad ribs (HP:0000885) | 2.29424037 |
71 | Thoracic kyphosis (HP:0002942) | 2.29207787 |
72 | Distal lower limb muscle weakness (HP:0009053) | 2.28028656 |
73 | Short nail (HP:0001799) | 2.27859090 |
74 | Respiratory difficulties (HP:0002880) | 2.26769908 |
75 | Vertebral compression fractures (HP:0002953) | 2.25767526 |
76 | Loss of speech (HP:0002371) | 2.25487286 |
77 | Poikiloderma (HP:0001029) | 2.23163157 |
78 | Hand muscle atrophy (HP:0009130) | 2.22823260 |
79 | Trismus (HP:0000211) | 2.22082810 |
80 | Eczematoid dermatitis (HP:0000976) | 2.21456036 |
81 | Pustule (HP:0200039) | 2.21013834 |
82 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.20949354 |
83 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.20893570 |
84 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.20893570 |
85 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.20315950 |
86 | Gastrointestinal inflammation (HP:0004386) | 2.19652530 |
87 | Bronchitis (HP:0012387) | 2.19535565 |
88 | IgM deficiency (HP:0002850) | 2.19280372 |
89 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.18722013 |
90 | Seborrheic dermatitis (HP:0001051) | 2.18553333 |
91 | Premature ovarian failure (HP:0008209) | 2.18552824 |
92 | Increased muscle lipid content (HP:0009058) | 2.17939262 |
93 | Vacuolated lymphocytes (HP:0001922) | 2.16912824 |
94 | Cerebral edema (HP:0002181) | 2.15140777 |
95 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.14977486 |
96 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.14977486 |
97 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.14977486 |
98 | Impaired platelet aggregation (HP:0003540) | 2.14929731 |
99 | Abnormal platelet function (HP:0011869) | 2.14929731 |
100 | Inflammation of the large intestine (HP:0002037) | 2.14107998 |
101 | Reduced antithrombin III activity (HP:0001976) | 2.13430720 |
102 | Entropion (HP:0000621) | 2.11888043 |
103 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.09377420 |
104 | Progressive neurologic deterioration (HP:0002344) | 2.08978147 |
105 | 3-Methylglutaconic aciduria (HP:0003535) | 2.07889725 |
106 | Hypertensive crisis (HP:0100735) | 2.07493393 |
107 | Hepatosplenomegaly (HP:0001433) | 2.07298592 |
108 | Urticaria (HP:0001025) | 2.06650784 |
109 | Deep palmar crease (HP:0006191) | 2.05753344 |
110 | Prolonged bleeding time (HP:0003010) | 2.04385119 |
111 | Myopathic facies (HP:0002058) | 2.04090487 |
112 | Abnormality of the thoracic spine (HP:0100711) | 2.01902907 |
113 | Increased IgM level (HP:0003496) | 2.01798361 |
114 | Cavernous hemangioma (HP:0001048) | 2.01106299 |
115 | Mediastinal lymphadenopathy (HP:0100721) | 2.00929495 |
116 | Cerebral aneurysm (HP:0004944) | 2.00296691 |
117 | Hoarse voice (HP:0001609) | 1.99684843 |
118 | Megalocornea (HP:0000485) | 1.98889927 |
119 | Colitis (HP:0002583) | 1.98275114 |
120 | Abnormal pupillary function (HP:0007686) | 1.97712911 |
121 | Hypokinesia (HP:0002375) | 1.97145923 |
122 | Increased serum ferritin (HP:0003281) | 1.96950961 |
123 | Fasciculations (HP:0002380) | 1.95541105 |
124 | Fatigue (HP:0012378) | 1.94843533 |
125 | Distal upper limb amyotrophy (HP:0007149) | 1.94710527 |
126 | Upper limb amyotrophy (HP:0009129) | 1.94710527 |
127 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.94147451 |
128 | 11 pairs of ribs (HP:0000878) | 1.93514652 |
129 | Papilloma (HP:0012740) | 1.92183146 |
130 | Verrucae (HP:0200043) | 1.92183146 |
131 | Acute necrotizing encephalopathy (HP:0006965) | 1.91641600 |
132 | Upper motor neuron abnormality (HP:0002127) | 1.91605084 |
133 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.91314976 |
134 | Secondary amenorrhea (HP:0000869) | 1.90233110 |
135 | Aplasia/Hypoplasia of the scapulae (HP:0006713) | 1.87666117 |
136 | Hypoplastic scapulae (HP:0000882) | 1.87666117 |
137 | Thick lower lip vermilion (HP:0000179) | 1.85320313 |
138 | Down-sloping shoulders (HP:0200021) | 1.84638630 |
139 | Death in infancy (HP:0001522) | 1.84637640 |
140 | Exertional dyspnea (HP:0002875) | 1.84582144 |
141 | Axonal loss (HP:0003447) | 1.83304562 |
142 | Emotional lability (HP:0000712) | 1.82989690 |
143 | Broad distal phalanx of finger (HP:0009836) | 1.82539284 |
144 | Increased connective tissue (HP:0009025) | 1.82147658 |
145 | Testicular atrophy (HP:0000029) | 1.81827417 |
146 | Spinal cord compression (HP:0002176) | 1.81643087 |
147 | Abnormal neuron morphology (HP:0012757) | 1.81618342 |
148 | Abnormality of the motor neurons (HP:0002450) | 1.81618342 |
149 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.81571968 |
150 | Hypoplasia of the odontoid process (HP:0003311) | 1.81215229 |
151 | Diaphragmatic weakness (HP:0009113) | 1.81090832 |
152 | Respiratory failure (HP:0002878) | 1.80553304 |
153 | Obstructive lung disease (HP:0006536) | 1.80541065 |
154 | Chronic obstructive pulmonary disease (HP:0006510) | 1.80541065 |
155 | Abnormality of the alveolar ridges (HP:0006477) | 1.80001077 |
156 | Basal cell carcinoma (HP:0002671) | 1.79821677 |
157 | Aortic regurgitation (HP:0001659) | 1.79512119 |
158 | Sparse eyelashes (HP:0000653) | 1.79195356 |
159 | Abnormality of the tricuspid valve (HP:0001702) | 1.78895114 |
160 | Depressed nasal ridge (HP:0000457) | 1.78197171 |
161 | Asplenia (HP:0001746) | 1.76932280 |
162 | Progressive muscle weakness (HP:0003323) | 1.75763271 |
163 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.74367489 |
164 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.74065092 |
165 | Mitochondrial inheritance (HP:0001427) | 1.72535101 |
166 | Petechiae (HP:0000967) | 1.71224274 |
167 | Missing ribs (HP:0000921) | 1.69899349 |
168 | Hepatocellular necrosis (HP:0001404) | 1.69819887 |
169 | Myositis (HP:0100614) | 1.69307464 |
170 | Absent thumb (HP:0009777) | 1.68783702 |
171 | Elbow flexion contracture (HP:0002987) | 1.68415752 |
172 | Migraine (HP:0002076) | 1.68325200 |
173 | Protuberant abdomen (HP:0001538) | 1.65953456 |
174 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.65742264 |
175 | Panhypogammaglobulinemia (HP:0003139) | 1.65583739 |
176 | Chin dimple (HP:0010751) | 1.63467515 |
177 | Increased density of long bones (HP:0006392) | 1.62990457 |
Rank | Gene Set | Z-score |
---|---|---|
1 | NME2 | 5.61542941 |
2 | VRK2 | 3.92247188 |
3 | TLK1 | 3.83692264 |
4 | MAP4K1 | 3.36626813 |
5 | TRIB3 | 2.97378164 |
6 | TESK1 | 2.91106229 |
7 | BCKDK | 2.75087816 |
8 | EPHA2 | 2.68614860 |
9 | STK16 | 2.63284052 |
10 | EEF2K | 2.59729124 |
11 | MAP3K10 | 2.56901040 |
12 | ERN1 | 2.34835515 |
13 | ARAF | 2.19522365 |
14 | MST1R | 2.12200753 |
15 | LIMK1 | 2.11533679 |
16 | DYRK3 | 2.02088587 |
17 | PKN2 | 1.94591794 |
18 | ICK | 1.90526073 |
19 | PIM2 | 1.86119696 |
20 | LRRK2 | 1.74009464 |
21 | TAOK2 | 1.72561359 |
22 | SRPK1 | 1.65479557 |
23 | NEK2 | 1.57975843 |
24 | SIK3 | 1.57501082 |
25 | RPS6KA4 | 1.51635597 |
26 | LMTK2 | 1.50844069 |
27 | RPS6KB2 | 1.43686800 |
28 | SMG1 | 1.40802470 |
29 | PBK | 1.40041294 |
30 | NME1 | 1.39837288 |
31 | GRK6 | 1.39302215 |
32 | MAP3K11 | 1.38266133 |
33 | MAP2K2 | 1.36151405 |
34 | ZAP70 | 1.26964537 |
35 | PDK2 | 1.25112499 |
36 | EPHB1 | 1.24296321 |
37 | EIF2AK1 | 1.24014175 |
38 | ABL2 | 1.21910587 |
39 | BUB1 | 1.20425610 |
40 | WEE1 | 1.19253124 |
41 | STK10 | 1.16056626 |
42 | TBK1 | 1.15624241 |
43 | CDC7 | 1.14267632 |
44 | TYK2 | 1.10404366 |
45 | CDK4 | 1.08610479 |
46 | CSF1R | 1.06882474 |
47 | MAP3K3 | 1.06411563 |
48 | MAPKAPK3 | 1.04455098 |
49 | FLT3 | 1.03985126 |
50 | BRAF | 1.03080456 |
51 | ILK | 1.03023819 |
52 | MAP3K8 | 1.01001237 |
53 | FES | 0.99340844 |
54 | SIK1 | 0.98532177 |
55 | MET | 0.97209427 |
56 | MAPKAPK5 | 0.96699482 |
57 | BTK | 0.95991915 |
58 | BLK | 0.94960764 |
59 | PAK4 | 0.94046375 |
60 | MST4 | 0.92555653 |
61 | DYRK1B | 0.92329636 |
62 | CSK | 0.92264872 |
63 | KIT | 0.91346475 |
64 | IKBKB | 0.90353804 |
65 | PIM1 | 0.90212500 |
66 | DAPK1 | 0.87888899 |
67 | MATK | 0.87869421 |
68 | PRPF4B | 0.87681228 |
69 | TAOK1 | 0.87188977 |
70 | CDK19 | 0.86620226 |
71 | DAPK3 | 0.85553926 |
72 | CDK7 | 0.85208732 |
73 | MAP2K3 | 0.84609064 |
74 | DMPK | 0.84515203 |
75 | PRKD2 | 0.82585468 |
76 | TEC | 0.82179890 |
77 | TGFBR1 | 0.78527758 |
78 | ALK | 0.77689109 |
79 | IRAK3 | 0.77644522 |
80 | SCYL2 | 0.76701193 |
81 | MAPK15 | 0.76028361 |
82 | PAK1 | 0.75608333 |
83 | RPS6KA5 | 0.74292797 |
84 | STK24 | 0.73307699 |
85 | AURKA | 0.71452630 |
86 | FGR | 0.71120955 |
87 | NEK1 | 0.71106801 |
88 | RPS6KC1 | 0.70898888 |
89 | RPS6KL1 | 0.70898888 |
90 | MAPK11 | 0.70744919 |
91 | RAF1 | 0.70040369 |
92 | HCK | 0.69907330 |
93 | TESK2 | 0.69647330 |
94 | RIPK4 | 0.67379126 |
95 | SYK | 0.65742668 |
96 | ERBB4 | 0.65277991 |
97 | RPS6KA6 | 0.64544185 |
98 | BMX | 0.64289590 |
99 | PRKCI | 0.63849107 |
100 | IRAK2 | 0.63664113 |
101 | PTK2 | 0.63649548 |
102 | PTK6 | 0.63362121 |
103 | VRK1 | 0.62760137 |
104 | TAOK3 | 0.62702793 |
105 | MAPKAPK2 | 0.62509799 |
106 | LCK | 0.62473352 |
107 | PRKG2 | 0.61836680 |
108 | TYRO3 | 0.61246573 |
109 | RPS6KA1 | 0.60712622 |
110 | TTN | 0.58578218 |
111 | PLK4 | 0.58383332 |
112 | AURKB | 0.58031262 |
113 | SIK2 | 0.57250010 |
114 | CDK8 | 0.56868379 |
115 | PAK2 | 0.56666273 |
116 | KDR | 0.56545097 |
117 | MAP3K1 | 0.56267511 |
118 | HIPK2 | 0.55259129 |
119 | MAP3K5 | 0.54705574 |
120 | TGFBR2 | 0.53903002 |
121 | IRAK4 | 0.52871011 |
122 | MARK3 | 0.51748284 |
123 | MAP2K6 | 0.50966202 |
124 | CDK9 | 0.50154761 |
125 | CDK6 | 0.50074112 |
126 | MOS | 0.48334653 |
127 | RET | 0.48268916 |
128 | BRSK2 | 0.47401418 |
129 | MAPK4 | 0.47378456 |
130 | IRAK1 | 0.47111076 |
131 | IKBKE | 0.46711117 |
132 | PDGFRA | 0.46150478 |
133 | CSNK1G3 | 0.45681424 |
134 | TTK | 0.45623891 |
135 | CDK14 | 0.45463944 |
136 | LYN | 0.44767989 |
137 | CLK1 | 0.44249041 |
138 | CAMK2D | 0.43973453 |
139 | CDK11A | 0.43474033 |
140 | PLK1 | 0.42873888 |
141 | BRSK1 | 0.42146770 |
142 | RPS6KA2 | 0.40302777 |
143 | CSNK2A2 | 0.40105387 |
144 | MAP3K12 | 0.39870581 |
145 | CSNK2A1 | 0.39386121 |
146 | CHEK1 | 0.35684011 |
147 | ATR | 0.35150501 |
148 | CDK15 | 0.31724947 |
149 | CDK18 | 0.31561297 |
150 | AKT2 | 0.31527871 |
151 | MAP2K7 | 0.25804331 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Ribosome_Homo sapiens_hsa03010 | 7.36296599 |
2 | DNA replication_Homo sapiens_hsa03030 | 3.18397010 |
3 | Spliceosome_Homo sapiens_hsa03040 | 2.70208486 |
4 | Homologous recombination_Homo sapiens_hsa03440 | 2.69320721 |
5 | Parkinsons disease_Homo sapiens_hsa05012 | 2.05102369 |
6 | Mismatch repair_Homo sapiens_hsa03430 | 1.98712579 |
7 | Base excision repair_Homo sapiens_hsa03410 | 1.88114086 |
8 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.80507983 |
9 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.76569720 |
10 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.71994977 |
11 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.61854223 |
12 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.59699160 |
13 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.58108384 |
14 | RNA transport_Homo sapiens_hsa03013 | 1.57032184 |
15 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.53146206 |
16 | Sulfur relay system_Homo sapiens_hsa04122 | 1.51249305 |
17 | RNA polymerase_Homo sapiens_hsa03020 | 1.51158879 |
18 | Thyroid cancer_Homo sapiens_hsa05216 | 1.44132198 |
19 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.42951466 |
20 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.42790103 |
21 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.39010520 |
22 | Alzheimers disease_Homo sapiens_hsa05010 | 1.37724324 |
23 | Galactose metabolism_Homo sapiens_hsa00052 | 1.37125365 |
24 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.34109706 |
25 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.32950822 |
26 | Huntingtons disease_Homo sapiens_hsa05016 | 1.29185491 |
27 | Bladder cancer_Homo sapiens_hsa05219 | 1.26936271 |
28 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.25208260 |
29 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.24656228 |
30 | Carbon metabolism_Homo sapiens_hsa01200 | 1.21017312 |
31 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.20102492 |
32 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.19136032 |
33 | Cell cycle_Homo sapiens_hsa04110 | 1.18351816 |
34 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.16836683 |
35 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.15833993 |
36 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.14115822 |
37 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.13943096 |
38 | Protein export_Homo sapiens_hsa03060 | 1.12142599 |
39 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.10831517 |
40 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.07428327 |
41 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.06082872 |
42 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.03027292 |
43 | Lysosome_Homo sapiens_hsa04142 | 1.01280622 |
44 | Proteasome_Homo sapiens_hsa03050 | 1.00537905 |
45 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.99146431 |
46 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.98029814 |
47 | Shigellosis_Homo sapiens_hsa05131 | 0.97759558 |
48 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.97346349 |
49 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.96338717 |
50 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.94103134 |
51 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.91457862 |
52 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.87539532 |
53 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.87199206 |
54 | Purine metabolism_Homo sapiens_hsa00230 | 0.86123303 |
55 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.85174878 |
56 | Leishmaniasis_Homo sapiens_hsa05140 | 0.84168013 |
57 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.82695945 |
58 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.81941184 |
59 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.81565526 |
60 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.81499208 |
61 | HTLV-I infection_Homo sapiens_hsa05166 | 0.80442441 |
62 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.80426589 |
63 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.79832667 |
64 | Viral myocarditis_Homo sapiens_hsa05416 | 0.79763772 |
65 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.79297219 |
66 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.78138392 |
67 | Apoptosis_Homo sapiens_hsa04210 | 0.78136615 |
68 | Basal transcription factors_Homo sapiens_hsa03022 | 0.77526243 |
69 | Alcoholism_Homo sapiens_hsa05034 | 0.76612194 |
70 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.76475702 |
71 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.76466951 |
72 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.76395907 |
73 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.74516668 |
74 | Phagosome_Homo sapiens_hsa04145 | 0.74135281 |
75 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.74004865 |
76 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.73840130 |
77 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.73788938 |
78 | Platelet activation_Homo sapiens_hsa04611 | 0.72575380 |
79 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.71344047 |
80 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.70764769 |
81 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.69564561 |
82 | Hepatitis B_Homo sapiens_hsa05161 | 0.69174521 |
83 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.68957677 |
84 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.68947897 |
85 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.67352425 |
86 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.67178086 |
87 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.67104517 |
88 | Measles_Homo sapiens_hsa05162 | 0.66968029 |
89 | Endocytosis_Homo sapiens_hsa04144 | 0.66426037 |
90 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.64205443 |
91 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.60073089 |
92 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.59965276 |
93 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.58852319 |
94 | RNA degradation_Homo sapiens_hsa03018 | 0.58362685 |
95 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.57822250 |
96 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.57444639 |
97 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.57115862 |
98 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.56677870 |
99 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.56520110 |
100 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.56211985 |
101 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.55769642 |
102 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.55587761 |
103 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.55006598 |
104 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.54268646 |
105 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.54141002 |
106 | Legionellosis_Homo sapiens_hsa05134 | 0.53500746 |
107 | Other glycan degradation_Homo sapiens_hsa00511 | 0.52441260 |
108 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.52287352 |
109 | Influenza A_Homo sapiens_hsa05164 | 0.51455933 |
110 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.50887269 |
111 | Metabolic pathways_Homo sapiens_hsa01100 | 0.49253344 |
112 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.48348864 |
113 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.47679155 |
114 | Salmonella infection_Homo sapiens_hsa05132 | 0.46809091 |
115 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.46490389 |
116 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.45070968 |
117 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.44766456 |
118 | Malaria_Homo sapiens_hsa05144 | 0.44731616 |
119 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.44165928 |
120 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.44064298 |
121 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.43132603 |
122 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.42771057 |
123 | Prostate cancer_Homo sapiens_hsa05215 | 0.42118052 |
124 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.42112767 |
125 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.42077685 |
126 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.41751117 |
127 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.39225016 |
128 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.38977258 |
129 | Glioma_Homo sapiens_hsa05214 | 0.38154730 |
130 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.37646460 |
131 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.37597165 |
132 | Tuberculosis_Homo sapiens_hsa05152 | 0.37004424 |
133 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.35217906 |